fetching data ...
version:
1.02
Home
Search:
Free Text Search
List:
Abstract Titles
Sessions
Authors
Keywords
Bookmarks
Include in search:
all years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
List: Sessions
Go!
Years:
2023 (Milan, Italy)
Total Number of items found:
157
in
16
pages.
Goto page:
10
50
100
Jump to page containing Sessions starting with :
A
B
C
D
E
F
G
H
I
L
M
N
O
P
R
S
T
U
V
W
Sessions
[2]
"Buy one - get 4 free" - RMDs and comorbidities
2023
2023 OP0009-PARE
CREATIVITY AND CO-PRODUCTION TO SUPPORT PEOPLE LIVING WITH CHRONIC PAIN WITH THEIR MENTAL HEALTH
,
L. Campbell, P. Callaghan, C. A. Chew-Graham, K. Dziedzic, N. Evans, T. Kingstone, L. Group, K. Stevenson
2023 OP0010-PARE
PRELIMINARY FINDINGS OF QUALITATIVE EXPLORATION OF THE EFFECTIVENESS OF AN ONLINE “FATIGUE AND ACTIVITY MANAGEMENT EDUCATION IN WORK” (FAME-W) INTERVENTION FOR INDIVIDUALS WITH INFLAMMATORY ARTHRITIS
,
S. Karkon, F. O’shea, R. Conway, M. Doran, A. O’ Gorman, H. Mccormack, B. Irudayaraj, D. Connolly
[1]
"So what now?" - living and planning life while co-existing with an RMD
2023
2023 OP0307-PARE
WHAT ARE THE UNMET NEEDS OF PREGNANT PATIENTS DIAGNOSED WITH INFLAMMATORY RHEUMATIC DISEASES RECEIVING CARE IN A HIGHLY SPECIALIZED REPRODUCTIVE RHEUMATOLOGY CENTER? THE RESULTS OF THE CAPRI STUDY
,
A. Van Steensel - Boon, H. Wintjes, L. F. Perez-Garcia, E. Röder, H. T. Smeele, L. J. Kranenburg - van Koppen, R. Dolhain
[1]
Neutrophil dysregulation in systemic lupus erythematosus
2023
2023 OP0293
ANTI-CITRULLINATED HISTONE MONOCLONAL ANTIBODY CIT-013, A DUAL ACTION THERAPEUTIC FOR NEUTROPHIL EXTRACELLULAR TRAP ASSOCIATED AUTOIMMUNE DISEASES
,
M. Van der Linden, S. Kumari, D. Montizaan, S. Van Dalen, A. Kip, M. Foster, I. Reinieren, E. Neubert, L. Erpenbeck, T. Bruurmijn, P. Van Zandvoort, P. Vink, E. Meldrum, H. Van Es, R. Chirivi
[2]
Single-cell omics in Rheumatic diseases
2023
2023 OP0185
IMMUNOPHENOTYPIC ABNORMALITIES REMINISCENT OF ESTABLISHED RHEUMATOID ARTHRITIS ARE PRESENT IN ACPA(+) AT-RISK INDIVIDUALS
,
M. Gillespie, Z. He, S. Rachid Zaim, L. Okada, J. Reading, A. Heubeck, C. Roll, P. Genge, M. Weiss, C. Phalen, R. Mettey, C. Speake, J. Buckner, D. Boyle, K. Demoruelle, K. A. Kuhn, F. Zhang, T. Bumol, V. M. Holers, P. Skene, X. J. LI, G. Firestein, T. Torgerson, K. Deane, A. Savage
2023 OP0186
DISTINCT PERIPHERAL IMMUNOPHENOTYPING UNDERLINES HISTOPATHOLOGICAL FEATURES IN PATIENTS WITH LUPUS NEPHRITIS IN A LARGE MULTI-CENTER COHORT
,
A. Horisberger, A. Griffith, J. Keegan, K. Howard, J. Pulford, E. Murzin, B. Hancock, T. Ghosh, T. Sasaki, A. Fava, M. Gutierrez Arcelus, T. Eisenhaure, J. Guthridge, A. Arazi, P. Hoover, M. Dall’era, D. Wofsy, D. L. Kamen, K. Kalunian, R. Furie, H. M. Belmont, P. Izmirly, R. Clancy, D. Hildeman, E. S. Woodle, W. Apruzzese, M. Mcmahon, J. Grossman, J. Barnas, F. Payan-Schober, M. Ishimori, M. Weisman, M. Kretzler, C. Berthier, J. Hodgin, C. Putterman, N. Hacohen, M. Brenner, J. H. Anolik, A. Davidson, J. A. James, S. Raychaudhuri, M. A. Petri, J. Buyon, B. Diamond, T. A. M. P. R. N. (Amp), F. Zhang, J. Lederer, D. Rao
[1]
0 – 100 in 75 minutes; RMDs have no age
2023
2023 OP0183-PARE
CO-DESIGNING JIA TOOLBOX: A PROOF-OF-CONCEPT STUDY ASSESSING PROTOTYPE INNOVATIONS TO HELP SELF-MANAGEMENT IN CHILDREN AND YOUNG PEOPLE WITH RHEUMATIC DISEASE
,
U. Ankeny, C. Dunbar, N. Dulake, J. Langley, D. Hawley
[10]
A novel journey into SLE, Sjogren and APS
2023
2023 POS0111
PILOT STUDY ON EVOKED COMPOUND ACTION POTENTIAL CONTROLLED CLOSED-LOOP SPINAL CORD STIMULATION IN TREATMENT OF RAYNAUD’S PHENOMENON
,
V. Schäfer, P. Karakostas, B. Dietz, G. Bara, J. Maciaczyk
2023 POS0112
DEUCRAVACITINIB REDUCES INTERFERONS, B-CELL PATHWAYS, AND SEROLOGICAL BIOMARKERS OF SYSTEMIC LUPUS DISEASE ACTIVITY: PHARMACODYNAMIC ANALYSIS FROM THE PHASE 2 PAISLEY STUDY
,
J. M. Kahlenberg, I. Sanz, C. Wu, Y. Hu, J. H. Kim, S. Singhal, I. M. Catlett
2023 POS0113
LONG-TERM REMISSIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES – A 25 YEARS SINGLE CENTER EXPERIENCE
,
T. Alexander, R. Biesen, G. R. Burmester, A. Radbruch, R. Arnold, F. Hiepe
2023 POS0114
A PLACEBO-CONTROLLED PHASE 1 STUDY IN HEALTHY ADULT VOLUNTEERS OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALPN-303, A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
,
S. R. Dillon, R. Davies, J. Lickliter, K. Mclendon, K. Manjarrez, A. Smith, M. Lessig, L. Blanchfield, R. Sanderson, A. Chunyk, T. Blair, A. Enstrom, H. Zayed, S. Peng
2023 POS0115
DAPIROLIZUMAB PEGOL EFFICACY BY SUBGROUPS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A POST HOC ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA
,
A. Askanase, C. Stach, C. Brittain, G. Stojan, R. Furie
2023 POS0116
EFFICACY AND SAFETY OF VOCLOSPORIN ACROSS PATIENT SUBGROUPS WITH PROTEINURIA ≥2 MG/MG: AN INTEGRATED ANALYSIS OF THE AURA-LV AND AURORA 1 STUDIES
,
E. Littlejohn, S. Almaani, V. Birardi, E. Yap, C. Collins
2023 POS0117
REMIBRUTINIB SPECIFICALLY DOWNREGULATES MARKERS OF MEMORY B CELL SUBSETS IN SJÖGREN’S PATIENTS (SJS) IN THE LOUISSE PHASE 2 CLINICAL TRIAL
,
A. Grioni, A. Santos Da Costa, E. Ferrero, V. De Luca, R. Hillenbrand, A. Da Costa, B. Cenni, M. Kaul, T. Dörner, R. Siegel
2023 POS0118
ADDING HYDROXYCHLOROQUINE IN REFRACTORY OBSTETRIC APS: OBSTETRIC OUTCOMES IN 182 PREGNANCIES
,
M. Gerde, R. Mac Kenzie, D. Viola, C. Heer, J. Balparda, E. Beruti
2023 POS0119
XmAb564, A NOVEL POTENCY-REDUCED IL-2 FC FUSION PROTEIN SELECTIVELY EXPANDS REGULATORY T CELLS: RESULTS FROM A SINGLE ASCENDING DOSE STUDY IN HEALTHY ADULT VOLUNTEERS
,
R. Clynes, C. Key, Y. Ding, L. LI, J. Woo, B. Sadler, J. Kanodia, H. Sun, R. Zitnik
2023 POS0120
SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR mAb) ADMINISTERED MONTHLY OVER 28 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
,
J. Cortés-Hernández, S. Ignatenko, A. Gordienko, N. Agmon-Levin, P. Narongroeknawin, K. Romanowska -Prochnicka, N. Shen, H. Ciferská, M. Kodera, J. C. C. Wei, P. Leszczynski, J. L. Lan, R. Wojciechowski, T. Tarr, E. Vishneva, Y. H. Chen, Y. Kaneko, S. Finzel, A. Hoi, M. Okada, A. Koolvisoot, S. S. Lee, L. Dai, H. Kaneko, B. Rojkovich, L. Sun, E. Zotkin, B. Magallares, T. Sengupta, C. Sips, S. Oliver
[8]
ABSTRACT OPENING PLENARY
2023
2023 OP0001
DECONVOLUTING IMMUNOLOGICAL AND CLINICAL HETEROGENEITY ACROSS AUTOIMMUNE RHEUMATIC DISEASES BY COHORT-WIDE IMMUNO-PHENOTYPING
,
H. Tanaka, Y. Okada, S. Nakayamada, Y. Miyazaki, S. Namba, K. Sonehara, Y. Shirai, K. Yamamoto, K. Sonomoto, Y. Tanaka
2023 OP0002
EXPLORING THE USE OF ARTIFICIAL INTELLIGENCE IN PREDICTING RHEUMATOID ARTHRITIS, BASED ON EXTREMITY MR SCANS IN EARLY ARTHRITIS AND CLINICALLY SUSPECT ARTHRALGIA PATIENTS
,
Y. Li, D. Shamonin, T. Hassanzadeh, M. Reijnierse, A. Van der Helm – van Mil, B. Stoel
2023 OP0003
TASK-SHIFTING IN HAND-OSTEOARTHRITIS CARE
,
A. Polster, L. Asphaug, A. T. Tveter, K. Bergsmark, B. Christensen, I. K. Haugen, M. Hermann-Eriksen, Å. Hove, A. Prøven, T. Hennig, T. A. Sjøvold, I. Kjeken
2023 OP0004
LUPUS100.ORG – A STEP CHANGE IN ACCESS TO QUALITY INFORMATION FOR EUROPEAN LUPUS PATIENTS
,
Z. Karakikla-Mitsakou, A. Cornet, I. D. Povilaite, M. Olsen, K. Blomkvist Sporre, N. Z. Serrano, M. Misuno
2023 OP0005
CAN AXIAL SPONDYLOARTHRITIS UNEQUIVOCALLY BE DIAGNOSED BY RHEUMATOLOGISTS IN PATIENTS WITH CHRONIC BACK PAIN OF LESS THAN TWO YEARS DURATION? MAIN RESULT OF THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT
,
M. L. Marques, S. Ramiro, M. Van Lunteren, R. Stal, I. J. Berg, K. Minde Fagerli, M. Van Oosterhout, S. Exarchou, R. Ramonda, M. G. H. Van de Sande, R. B. M. Landewé, D. Van der Heijde, F. A. Van Gaalen
2023 OP0006
INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID OR PSORIATIC ARTHRITIS STARTING BDMARDS: INCIDENCE VS. GENERAL POPULATION, AND THE ROLE OF METHOTHREXATE CO-MEDICATION
,
S. Aarrestad Provan, L. Ljung, E. Kristianslund, B. Michelsen, T. Uhlig, T. Love, J. Sexton, B. Gudbjornsson, D. DI Giuseppe, M. L. Hetland, G. B. Reynisdóttir, B. Glintborg, H. Relas, K. Aaltonen, T. K. Kvien, J. Askling
2023 OP0007
INCIDENCE, PREVALENCE AND CO-OCCURRENCE OF AUTOIMMUNE DISORDERS, TRENDS OVER TIME AND BY AGE, SEX AND SOCIOECONOMIC STATUS. A POPULATION-BASED STUDY IN 22 MILLION INDIVIDUALS.
,
N. Conrad, S. Misra, J. Verbakel, G. Verbeke, G. Molenberghs, P. Taylor, J. Mason, N. Sattar, J. Mcmurray, I. Mcinnes, K. Khunti, G. Cambridge
2023 OP0008
EULAR RECOMMENDATIONS FOR THE USE OF IMAGING IN THE DIAGNOSIS AND MANAGEMENT OF CRYSTAL-INDUCED ARTHROPATHIES IN CLINICAL PRACTICE
,
P. Mandl, M. A. D’agostino, V. Navarro-Compán, I. Gessl, G. Sakellariou, A. Abhishek, F. Becce, N. Dalbeth, H. K. Ea, E. Filippucci, H. B. Hammer, A. Iagnocco, A. De Thurah, E. Naredo, S. Ottaviani, T. Pascart, F. Perez-Ruiz, I. Pitsillidou, F. Proft, J. Rech, W. A. Schmidt, L. M. Sconfienza, L. Terslev, B. Wildner, P. Zufferey, G. Filippou
[31]
Adaptive immunity (T cells and B cells) in rheumatic diseases
2023
2023 AB0007
DYNAMIC INTERPLAY OF FUNCTIONALLY DISCORDANT CD4+HLA-DR+ SUBSETS WITH A COMMON PATHOLOGICAL ONTOGENIC ORIGIN IN HUMAN ARTHRITIS
,
J. Y. Leong, P. Kumar, A. J. M. Lim, S. H. Tay, S. Hazirah, J. G. Yeo, C. Chua, P. Chen, A. M. Lajam, A. Consolaro, M. Gattorno, C. T. Ng, T. Arkachaisri, A. Martini, S. Albani
2023 AB0008
ROLE OF IL-23/TH17 AXIS CYTOKINES IN RHEUMATOID ARTHRITIS
,
J. Meher, S. Patel, M. S. Siddiqui, R. Nanda
2023 AB0009
UNTREATED EARLY RHEUMATOID ARTHRITIS PATIENTS HAVE AN ABNORMAL DISTRIBUTION OF B AND FOLLICULAR T HELPER CELL SUBSETS IN PERIPHERAL BLOOD
,
C. Tomé, R. L. Teixeira, S. C. Barreira, P. Martins, J. Polido-Pereira, A. Valido, M. J. Saavedra, C. Ponte, R. Barros, V. C. Romão, L. Graca, J. E. Fonseca, R. A. Moura
2023 AB0010
FERROPTOSIS PROMOTES DYSFUNCTION OF NTREG BUT NOT ITREG IN RHEUMATOID ARTHRITIS
,
J. Chen, J. Zhao, X. Shi, Y. Liu, Y. Jiang, Y. Pan, S. Zheng
2023 AB0011
CYTOMETRIC ANALYSIS OF ACTIVATED ENTHESEAL TISSUE RESIDENT T-CELLS REVEALS IL-17F AS THE DOMINANT IL-17 ISOFORM EXPRESSED BY INNATE AND ADAPTIVE LYMPHOCYTES
,
N. Mcdermott, T. Macleod, A. S. Rao, V. Borse, P. Loughenbury, R. Dunsmuir, A. Khan, A. Maroof, D. Mcgonagle
2023 AB0012
ANALYSIS OF THE EXPRESSION OF T-BET IN B LYMPHOCYTES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
,
E. Marasco, G. M. Moneta, C. Bracaglia, I. Caiello, C. Farroni, R. Carsetti, F. De Benedetti
2023 AB0013
LONGITUDINAL CHANGES IN VARICELLA ZOSTER VIRUS (VZV)-SPECIFIC T CELL IMMUNITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH DIFFERENT JAK INHIBITORS
,
S. Moustafa, C. G. Gialouri, K. Thomas, C. Koutsianas, C. Tsalapaki, A. Panagiotopoulos, E. Mavrea, K. Antonatou, E. Hadziyannis, D. Vassilopoulos
2023 AB0014
IMMUNE RESPONSES TO VACCINATION AGAINST HERPES ZOSTER (HZ) IN PATIENTS WITH RHEUMATIC DISEASES UNDER TREATMENT WITH JAK-INHIBITORS: OUR PRELIMINARY RESULTS
,
C. Sieiro Santos, A. López Robles, C. Álvarez Castro, S. Calleja Antolín, C. Moriano, E. Diez Alvarez, J. M. Garcia Ruiz de Morales
2023 AB0015
ANTINUCLEAR ANTIBODIES PATTERN CLASSIFIER WITH CONVOLUTIONAL NEURAL NETWORKS
,
V. Alfaro, A. Carpio, Y. Stekman
2023 AB0016
HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS
,
O. Ozdemir Isik, E. Basaran, D. Temiz Karadağ, A. Yazici, A. Cefle
2023 AB0017
HOW DO B CELLS EVADE RITUXIMAB THERAPY IN AUTOIMMUNITY; IS IT TIME TO TARGET THE CD19+CD20- B CELLS?
,
K. Shah, C. Klein, G. Cambridge, D. Sen, M. Castelino, A. Akbar, D. Isenberg, M. J. Leandro, V. Reddy
2023 AB0018
IMPACT OF AN EX-NOVO INDUCED ADAPTIVE IMMUNE RESPONSE ON CXCL13 SERUM LEVELS IN ESTABLISHED AUTOANTIBODY-POSITIVE RHEUMATOID ARTHRITIS
,
E. Bozzalla Cassione, M. Mansoubi, T. Luvaro, I. Mazzucchelli, B. Xoxi, L. De Stefano, S. Bugatti, C. Montecucco, A. Manzo
2023 AB0019
AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
,
C. Aude, N. Ghosh, D. Jannat-Khah, K. K. Chan, M. Postow, H. Larman, A. Bass
2023 AB0020
CYTOCHEMICAL ASSESSMENT IN TREG CELLS OF PSORIASIC ARTHROPATHY BY INHIBITION OF IL23 (IN REAL LIFE) AND ITS CORRELATION WITH CLINICAL REMISSION
,
F. J. Navarro Blasco, S. Pascual
2023 OP0014
SHARED MOLECULAR TARGETS OF APOPTOSIS IN CHRONIC INFLAMMATION AND AUTOIMMUNITY: HOW TO BLOCK AUTOIMMUNE ARTHRITIS
,
J. Paris, L. Ghezil, L. Tourneur, G. Bousquet, G. Falgarone
2023 OP0015
CD38HI CYTOTOXIC CD8 T CELLS ARE EXPANDED FOLLOWING CHECKPOINT BLOCKADE AND CHARACTERIZE THE T CELL INFILTRATE IN CHECKPOINT INHIBITOR-ASSOCIATED ARTHRITIS
,
A. Singaraju, K. E. Marks, R. Wang, L. Shakib, G. Dunlap, A. Cunningham-Bussel, S. R. Greisen, L. Chen, A. Tirpack, M. Fein, I. Adejoorin, D. Todd, L. Macfarlane, S. Goodman, E. Dicarlo, E. Massarotti, J. Sparks, A. H. Jonsson, M. Brenner, M. Postow, K. K. Chan, A. Bass, D. Rao, L. Donlin
2023 OP0016
ABATACEPT TO SILENCE ANTI-CITRULLINATED PROTEIN ANTIBODY-EXPRESSING B CELLS IN RHEUMATOID ARTHRITIS: THE ASCARA TRIAL
,
N. Blomberg, J. Kwekkeboom, S. Böhringer, T. Huizinga, R. Toes, H. U. Scherer
2023 OP0017
ACTIVE LUPUS NEPHRITIS PATIENTS DISPLAY AN INCREASED PROPORTION OF RECENTLY ACTIVATED NAÏVE DNA-REACTIVE B CELLS
,
K. Wangriatisak, F. Faustini, R. Kumar, C. De Vries, P. Pisitkun, P. Chootong, V. Malmström, I. Gunnarsson
2023 OP0019
PREMATURE AGING IN LYMPH NODE STROMAL CELLS OF PATIENTS WITH RHEUMATOID ARTHRITIS PARTY RESTORED BY DASATINIB TREATMENT
,
T. De Jong, J. F. Semmelink, J. W. Bolt, C. Grasso, R. A. Hoebe, P. Krawczyk, L. Van Baarsen
2023 OP0020
THE CELLULAR METABOLISM OF SLE NK CELLS IS PRIMARILY ALTERED AT THE LEVEL OF MITOCHONDRIAL HOMEOSTASIS
,
N. Fluder, M. Humbel, C. Ribi, D. Comte
2023 OP0021
STRATIFICATION OF PATIENTS WITH SJÖGREN’S SYNDROME BY JOINT MULTI-MODAL ANALYSIS OF CIRCULATING B CELLS
,
G. Arvidsson, P. Czarnewski, A. Johansson, A. Raine, J. Imgenberg-Kreuz, J. Nordlund, G. Nordmark, A. C. Syvänen
2023 POS0001
A NOVEL METHOTREXATE TARGET TP63 SUPPRESSES FOXP3 EXPRESSION AND EXACERBATES AUTOIMMUNE ARTHRITIS
,
K. Suga, A. Suto, S. Tanaka, T. Kageyama, J. Ishikawa, A. Iwata, S. Furuta, K. Ikeda, K. Suzuki, H. Nakajima
2023 POS0002
MICROBIOTA-DERIVED HISTAMINE INDUCES RESOLUTION OF SYNOVIAL INFLAMMATION VIA CELLS OF THE NERVOUS SYSTEM
,
K. Dürholz, E. Schmid, M. Frech, M. Linnerbauer, L. Lößlein, S. Lucas, V. Azizov, F. Schälter, J. Hofmann, A. Iljazovic, T. Strowig, V. Taudte, M. Fromm, W. Xiang, C. Akdis, V. Rothhammer, G. Schett, M. Zaiss
2023 POS0003
HUMAN LYMPH NODE STROMAL CELLS MAINTAIN FOXP3+ REGULATORY T CELLS IN A HLA-DR DEPENDENT MANNER
,
C. Grasso, A. M. O’byrne, J. F. Semmelink, E. Remmerswaal, J. W. Bolt, R. Mebius, L. Van Baarsen
2023 POS0004
PRO-INFLAMMATORY ANTI-MODIFIED PROTEIN AUTOANTIBODIES DERIVED FROM BONE MARROW, SYNOVIAL, AND LUNG B CELLS PREFERENTIALLY TARGET MALONDIALDEHYDE-ACETALDEHYDE CROSS-LINKED MOLECULAR STRUCTURES
,
P. Sahlström, M. Gomes Afonso, V. Joshua, V. Valkovskaia, R. Stålesen, L. Israelsson, M. Hansson, D. Scheel-Toellner, L. Klareskog, A. Hensvold, V. Malmström, B. Réthi, C. Grönwall
2023 POS0005
IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOSITIS, MUSCLE-RESTRICTED TCR CLONES SHARE STRUCTURAL FEATURES, WHILE THEIR EXPANSION CORRELATES WITH DISEASE ACTIVITY
,
D. Anang, H. Walter, G. Balzaretti, J. Lim, A. Olivieri, L. Van der Weele, I. Niewold, E. Aronica, F. Eftimov, J. Raaphorst, B. Van Schaik, A. Van Kampen, A. J. Van der Kooi, N. De Vries
2023 POS0006
AUTOREACTIVE B CELLS IN RHEUMATOID ARTHRITIS ARE RECENTLY ACTIVATED AND SHOW LARGE EXPANSIONS OF CXCR3+ ANTIBODY-SECRETING CELLS
,
S. Reijm, J. Kwekkeboom, N. Blomberg, J. Suurmond, D. Van der Woude, R. Toes, H. U. Scherer
2023 POS0007
KYV-101, A FULLY HUMAN CD19 CAR T CELL GENERATED FROM AUTOIMMUNE PATIENT LYMPHOCYTES, DEMONSTRATES CAR-MEDIATED AND CD19-DEPENDENT ACTIVITY AGAINST AUTOLOGOUS B CELLS
,
S. Park, A. Register, H. Y. Lee, G. Lutzny-Geier, M. Aigner, M. Andreas, G. Schett, D. Borie, J. Chung, C. Kaplan
2023 POS0008
STRATIFICATION OF NEGATIVE, SEROCONVERTED AND PERSISTENTLY POSITIVE THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME PATIENTS WITH DISTINCT FOLLICULAR HELPER T CELLS SUBSETS
,
P. Gaspar, A. R. Cruz-Machado, F. Ribeiro, V. C. Romão, L. Graca
2023 POS0009
LYMPH NODES AND PERIPHERAL BLOOD HARBOR EXPANDED T CELL RECEPTOR CLONES DURING THE PRECLINICAL PHASE OF RHEUMATOID ARTHRITIS WHICH PERSIST ON ARTHRITIS ONSET
,
D. Anang, G. Balzaretti, A. Olivieri, A. Al-Soudi, I. Niewold, J. F. Semmelink, B. Van Schaik, A. Van Kampen, D. Gerlag, P. P. Tak, M. G. H. Van de Sande, L. Van Baarsen, N. De Vries
2023 POS1008
INVESTIGATING ANTIGEN SPECIFIC T CELLS AND THEIR CITRULLINATED PROTEIN TARGETS IN SYNOVIAL TISSUE
,
E. A. James, C. Rims, S. Posso, J. Carlin, W. Kwok, S. E. Ong, J. Buckner
[7]
Advances in imaging in rheumatic musculoskeletal disorders
2023
2023 OP0169
VESSEL WALL INFLAMMATION DETECTED WITH SUPERB MICROVASCULAR IMAGING IN BEHÇET SYNDROME
,
Y. Kayadibi, Y. Ozguler, M. Melikoglu, S. N. Esatoglu, U. Kimyon, A. Kalyoncu Ucar, İ. Adaletli, G. Hatemi
2023 OP0170
INTEROSSEOUS TENDON INFLAMMATION ACROSS THE EARLY ARTHRITIS SPECTRUM: A 10-YEAR MRI-STUDY INVESTIGATING ITS PREVALENCE AT DIAGNOSIS AND RELATION WITH CLINICAL SIGNS
,
B. Van Dijk, N. Den Hollander, M. Reijnierse, A. Van der Helm – van Mil
2023 OP0171
ADDED VALUE OF FDG-PET/CT TO DETECT AORTIC INVOLVEMENT IN PATIENTS WITH ULTRASOUND PROVEN GIANT CELL ARTERITIS
,
J. Molina Collada, I. Castrejon, I. Monjo, E. Fernández-Fernández, G. Torres Ortiz, J. Martínez-Barrio, J. M. Alvaro-Gracia, E. De Miguel
2023 OP0172
LIMITED DIAGNOSTIC AND PROGNOSTIC VALUE OF RADIOGRAPHS OF HANDS AND FEET IN PATIENTS WITH UNDIFFERENTIATED ARTHRITIS SUSPECTED FOR RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT STUDY
,
E. Ulijn, N. Den Broeder, D. Ten Cate, K. Van Overdijk, H. Demirel, R. B. M. Landewé, N. Van Herwaarden, A. Den Broeder
2023 OP0173
CHARACTERIZATION OF AXIAL INVOLVEMENT USING 18F-FLUORIDE PET-CT IN SPONDYLOARTHRITIS PATIENTS
,
I. Giovannini, A. Zabotti, S. Diodato, C. Cicciò, M. Salgarello, D. Mcgonagle, I. Tinazzi
2023 OP0174
CHEST RADIOGRAPHS PRE-IMMMUNOSUPPRESSION HELP TO IDENTIFY NON TUBERCULOUS INFECTIONS AND INTERSTITIAL LUNG DISEASES, BUT ADD LITTLE TO LATENT TUBERCULOSIS SCREENING
,
R. Harrington, I. Khan, M. Ramakrishnan, F. Fitzpatrick, L. Durcan
2023 OP0175
RELEVANT FEATURES IN FLUORESCENCE OPTICAL IMAGING FOR DIFFERENTIAL DIAGNOSIS OF RHEUMATIC DISEASES AFFECTING THE HANDS
,
N. Stumper, J. Berger, V. Failli, E. Gedat, P. Hoff, G. Schmittat, A. Briel, G. R. Burmester, S. Ohrndorf
[11]
Advances in our care of children and young people with JIA
2023
2023 POS0277
SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED LUNG DISEASE IN EUROPE
,
C. Bracaglia, F. Minoia, C. Kessel, S. Vastert, M. Pardeo, A. Arduini, Ö. Basaran, N. Kiper, M. Kostik, M. Glerup, S. Fingerhutova, R. Caorsi, A. Horne, G. Filocamo, H. Wittkowski, M. Jelusic, J. Anton, S. Khaldi-Plassart, A. Belot, G. Horneff, S. Palmer Sarott, E. Cannizzaro, P. Doležalová, A. Ravelli, S. Ozen, F. De Benedetti
2023 POS0278
EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL
,
N. Ruperto, I. Foeldvari, E. Alexeeva, N. Aktay Ayaz, G. Schulert, S. Özen, A. Popov, A. Ramanan, C. Scott, B. Sozeri, E. Zholobova, S. Chakraborty, X. Zhu, R. Martin, S. Whelan, S. Kaur, L. Pricop, D. J. Lovell, A. Martini, H. Brunner
2023 POS0279
IDENTIFICATION OF PREDICTIVE FACTORS OF FLARE AFTER ANAKINRA WITHDRAWAL IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE CENTRE
,
G. Nardini, C. Bracaglia, D. Pires Marafon, E. Sacco, A. De Matteis, I. Caiello, G. Prencipe, F. De Benedetti, M. Pardeo
2023 POS0280
EARLY EXPERIENCE WITH JAK INHIBITORS IN JIA IN ROUTINE CLINICAL PRACTICE
,
L. Kearsley-Fleet, E. Baildam, M. Beresford, S. Douglas, H. Foster, T. Southwood, K. Hyrich
2023 POS0281
SAFETY OF BIOSIMILARS THERAPIES FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE SPANISH REGISTRY OF ADVERSE EVENTS WITH BIOLOGIC THERAPIES (BIOBADASER)
,
J. J. Bethencourt Baute, L. Otero-Varela, F. J. Manero Ruiz, E. Perez-Pampín, C. Rodríguez-Lozano, S. Manrique Arija, S. Bustabad, C. Fernández-López, D. Ruiz Montesinos, L. Mateo, R. Martín-Domenech, M. Moreno, F. Sánchez-Alonso, I. Catrejón
2023 POS0282
PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) ON INTENSIVE TREATMENT FREQUENTLY PRESENT ALEXITHYMIA OVER FATIGUE, ANXIETY, AND DEPRESSION, DESPITE LOW DISEASE ASSESSMENT PARAMETERS
,
M. S. Nicoli, G. Tarantino, E. Marasco, E. Betti, M. F. Paniccia, T. Grimaldi, A. Aquilani, R. Nicolai, F. De Benedetti, S. Magni-Manzoni
2023 POS0283
EFFECT OF CUSTOMISED FOOT ORTHOSES ON PEAK PRESSURE AND PRESSURE TIME INTEGRALS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A RANDOMISED CLINICAL TRIAL
,
A. Fellas, D. Singh-Grewal, J. Chaitow, D. Santos, M. Clapham, A. Coda
2023 POS0284
COVID-19 SYMPTOMS AND DISEASE COURSE IN GERMAN PEDIATRIC RHEUMATOLOGY PATIENTS REPORTED TO BIKER
,
A. Klein, T. Hospach, F. Dressler, D. Windschall, M. Hufnagel, W. Emminger, S. Mrusek, P. Ruehmer, A. Kühn, P. Bismarck, M. Haller, G. Horneff
2023 POS0285
TEMPOROMANDIBULAR JOINT INVOLVEMENT IN JUVENILE IDIOPATHIC ARTHRITIS: THE ROLE OF MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF THE SILENT JOINT
,
C. Brusadelli, D. Mariano, A. Pistorio, L. Anfigeno, F. Magnaguagno, M. Valle, M. DI Filippo, G. Chiappe, N. Laffi, C. Malattia
2023 POS0286
TREATMENT OF A LARGE COHORT OF CHILDHOOD CHRONIC IDIOPATHIC UVEITIS: A MULTICENTRIC LARGE COHORT
,
I. Maccora, C. Guly, C. De Libero, R. Caputo, A. Ramanan, G. Simonini
2023 POS0287
TOFACITINIB IN JUVENILE IDIOPATHIC ARTHRITIS: FIRST YEAR EXPERIENCE
,
G. Horneff, D. Windschall, B. Huegle, R. Berendes, H. Girschick, A. Klein
Goto page:
10
50
100
